Results 231 to 240 of about 189,147 (282)
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie +3 more
wiley +1 more source
Tracing the origin and evolution of specialized biosynthetic pathways in marine organisms. [PDF]
Martinelli L +3 more
europepmc +1 more source
CD36-PPARγ-SPP1 axis mediates hepatocyte-macrophage coordination to drive MASLD-related liver fibrosis. [PDF]
Dai Z +12 more
europepmc +1 more source
PiggyBac-mediated transgenesis and CRISPR-Cas9 knockout in the greater wax moth, Galleria mellonella. [PDF]
Pearce JC +4 more
europepmc +1 more source
Academic Symposium: Empowering the Next Generation to Drive Global Impact in Biomedical Innovation. [PDF]
europepmc +1 more source
Retinoblastoma: unveiling molecular pathogenesis and pioneering organoid-driven therapeutic innovations. [PDF]
Li H, Jin C.
europepmc +1 more source
High-level prodigiosin production in <i>Pseudomonas putida</i> enabled by combinatorial metabolic engineering. [PDF]
Zhang Y +7 more
europepmc +1 more source

